PARP-1 inhibitors (GlaxoSmithKline)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePARP-1 inhibitors (GlaxoSmithKline)
Drug Alias NamePARP-1 inhibitors (University of Florence/GlaxoSmithKline)TIQ-A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) polymerase inhibitors
TargetsPoly (ADP-Ribose) polymerase
Therapy Area/IndicationsStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversita degli Studi di Firenze
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsStroke

Other Information

ATC CodeN/A
Related LinksN/A